Streetbeat News

Products Services

STLA

Stellantis has expressed interest in North American brands while reaffirming its commitment to its entire portfolio. This indicates potential strategic moves in the North American market.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 2:16 pm

BTCUSD

Blake Benthall, founder of Fathom X and former creator of Silk Road 2.0, discusses the evolution of the crypto industry with former FBI agent Vincent Agostino. They highlight the maturation of the crypto space, the importance of transparency, and the increasing mainstream adoption of Bitcoin.

Portfolio Pulse from Khyathi Dalal

August 30, 2024 | 2:03 pm

DRN

ERX

ERY

FAS

FAZ

LABD

LABU

QQQE

SOXL

SOXS

UTSL

Direxion's Ed Egilinsky discusses sectors likely to benefit from potential Federal Reserve rate cuts and the 2024 presidential election. Key sectors include Financials, Energy, Tech, and Healthcare/Biotech. Leveraged ETFs like SOXL, SOXS, LABU, LABD, ERX, ERY, FAS, FAZ, and others are highlighted for capturing sector volatility.

Portfolio Pulse from Surbhi Jain

August 30, 2024 | 1:59 pm

EBS

GOVX

MRNA

The WHO Chief, Tedros, announced that Mpox vaccines could be ready for emergency use listing within two weeks, with some vaccines expected to arrive in Congo soon.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 1:57 pm

BAVA

KM Biologics

The WHO has received its first expression of interest for emergency use listing from a Mpox diagnostics manufacturer. WHO officials also discussed polio vaccination plans in Gaza and confirmed applications from Bavarian Nordic and KM Biologics for Mpox vaccines emergency use listing, with 230,000 doses available for Congo.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 1:55 pm

LLY

NVO

Novo Nordisk's semaglutide, marketed as Wegovy and Ozempic, shows promise in reducing heart failure complications, with a 31% reduction in cardiovascular events. However, it is not yet approved for heart failure outcomes in the US. The study also highlights potential in treating other conditions like cancer. Novo Nordisk's stock saw a slight increase following the news.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 1:54 pm

ALNY

BBIO

PFE

Alnylam Pharmaceuticals' stock fell after presenting detailed results from the HELIOS-B Phase 3 study of vutrisiran for ATTR amyloidosis with cardiomyopathy. Despite positive data on mortality reduction, the stock dropped 5.9%.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 1:51 pm

LMT

Lockheed Martin has resumed F-35 jet deliveries to the U.S. military, but the U.S. government is withholding $5 million per jet until a technology upgrade is completed. This impacts Lockheed's profit margins, as the F-35 program is a significant part of their sales. The company aims to deliver 100 jets this year and over 150 by 2025.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 1:46 pm

NVDA

Nvidia reported a 122% increase in Q2 revenues, reaching $30 billion, surpassing expectations. Despite strong financials, Nvidia's stock fell 6% in after-hours trading, likely due to high market expectations. The company plans to launch the Blackwell chip in Q4, expected to boost revenue further.

Portfolio Pulse from Zaheer Anwari

August 30, 2024 | 1:44 pm

ALNY

Alnylam Pharmaceuticals reported a typo in their presentation that misstated the benefits of their heart drug. This error was clarified during a company call.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 1:42 pm